New Miebach Study about the Future of Pharma Supply Chains available - Digital Tools and AI gain in Importance
Frankfurt am Main, April 16, 2024
The pharmaceutical supply chain industry has undergone significant transformations in the wake of several “black swan” events that have battled the world economy over the past few years. Miebach's new international study from 2024 with over 300 participants reflects the evolving needs and drastic shifts in priorities of the pharmaceutical supply chain, offering strategic recommendations to overcome challenges and capitalize on emerging opportunities.
Read more and download the Miebach Study about the Future of Pharma Supply Chains available |
Contact